财务摘要（报告期）（Lisata Therapeutics Inc）
| 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|
| 每股指标： | ||||||||
| 每股收益EPS基本(元) | -2.58 | -1.92 | -1.28 | -0.77 | -10.47 | -22.56 | -0.18 | -0.07 |
| 每股净资产(元) | 5.91 | 6.51 | 7.13 | 7.62 | 8.46 | 9.16 | 1.36 | 1.46 |
| 每股经营现金净流量(元) | -2.46 | -1.96 | -1.52 | -1.02 | -2.69 | -1.87 | -0.18 | -0.09 |
| 每股现金流量净额(元) | -1.17 | 0.03 | -1.04 | -0.50 | 0.95 | 0.87 | 0.14 | -0.20 |
| 盈利能力： | ||||||||
| 净资产收益率平均(%) | -36.33 | -25.89 | -16.40 | -9.70 | -68.28 | -117.45 | -12.43 | -4.68 |
| 总资产净利率(%) | -32.63 | -23.60 | -15.09 | -8.88 | -63.78 | -109.91 | -11.87 | -4.48 |
| 投入资本回报率ROIC(%) | -56.72 | -46.16 | -25.51 | -15.55 | -95.34 | -160.89 | -17.31 | -5.58 |
| 收益质量： | ||||||||
| 营业利润／利润总额(%) | 110.95 | 110.55 | 109.37 | 110.62 | 101.58 | 100.68 | 100.07 | 98.73 |
| 资本结构： | ||||||||
| 资产负债率(%) | 12.43 | 9.27 | 7.46 | 8.48 | 9.19 | 8.61 | 4.36 | 3.52 |
| 权益乘数 | 1.14 | 1.10 | 1.08 | 1.09 | 1.10 | 1.09 | 1.05 | 1.04 |
| 产权比率 | 0.14 | 0.10 | 0.08 | 0.09 | 0.10 | 0.09 | 0.05 | 0.04 |
| 流动资产／总资产(%) | 98.59 | 98.53 | 98.49 | 98.45 | 98.41 | 98.42 | 87.27 | 99.17 |
| 非流动资产／总资产(%) | 1.41 | 1.47 | 1.51 | 1.55 | 1.59 | 1.58 | 12.73 | 0.83 |
| 流动负债／负债合计(%) | 96.91 | 95.30 | 93.66 | 94.01 | 95.13 | 94.57 | 89.76 | 86.93 |
| 非流动负债／负债合计(%) | 3.09 | 4.70 | 6.34 | 5.99 | 4.87 | 5.43 | 10.24 | 13.07 |
| 归属母公司股东的权益／投入资本(%) | 148.81 | 204.35 | 148.91 | 158.64 | 161.86 | 152.26 | 156.09 | 112.06 |
| 偿债能力： | ||||||||
| 流动比率 | 8.18 | 11.15 | 14.10 | 12.35 | 11.26 | 12.09 | 22.33 | 32.38 |
| 速动比率 | 8.18 | 11.15 | 14.10 | 12.35 | 11.26 | 12.09 | 22.33 | 32.38 |
| 货币资金／流动负债(%) | 342.84 | 631.88 | 543.85 | 532.63 | 503.74 | 492.54 | 993.39 | 455.09 |
| 营业利润／流动负债(%) | -390.11 | -383.53 | -314.94 | -129.47 | -902.41 | -1,597.90 | -397.38 | -236.34 |
| 经营活动产生的现金流量净额／流动负债(%) | -303.98 | -311.05 | -284.21 | -155.05 | -331.66 | -230.04 | -318.86 | -201.43 |
| 归属母公司股东的权益／负债合计(%) | 708.06 | 983.44 | 1,246.36 | 1,084.07 | 992.22 | 1,065.77 | 2,202.97 | 2,746.59 |
| 经营活动产生的现金流量净额／负债合计(%) | -294.59 | -296.43 | -266.18 | -145.76 | -315.50 | -217.55 | -286.20 | -175.11 |
| 营业利润／负债合计(%) | -378.06 | -365.52 | -294.97 | -121.71 | -858.44 | -1,511.13 | -356.68 | -205.46 |
| 成长能力： | ||||||||
| 总资产同比增长率(%) | -25.11 | -26.03 | -27.38 | -27.48 | -24.71 | -23.41 | -20.93 | -20.19 |
| 每股净资产同比增长率(%) | -30.20 | -28.97 | 424.14 | 421.31 | 448.55 | 455.01 | -22.86 | -21.12 |
| 总负债同比增长率(%) | 1.34 | -20.32 | 24.36 | 74.52 | 33.99 | 63.83 | -4.96 | -29.85 |
| 基本每股收益同比增长率(%) | 75.36 | 82.98 | 52.42 | 26.67 | -40.54 | -95.83 | 33.33 | 63.16 |
| 归属母公司股东的权益同比增长率(%) | -27.68 | -26.47 | -29.64 | -31.12 | -27.83 | -27.00 | -21.48 | -19.75 |
| 营业利润同比增长率(%) | 55.37 | 61.45 | -2.84 | -3.38 | -98.28 | -129.99 | 12.43 | 18.13 |
| 股东权益合计同比增长率(%) | -27.79 | -26.57 | -29.73 | -31.21 | -27.91 | -27.07 | -21.53 | -19.79 |
| 营运能力： | ||||||||
| 衍生指标： | ||||||||
| 现金及现金等价物净增加额TTM(元) | -9,561,000.00 | 950,000.00 | -9,658,000.00 | 15,408,000.00 | 7,507,000.00 | 18,706,000.00 | 20,413,000.00 | -15,997,000.00 |
| 利润总额TTM(元) | -23,170,000.00 | -23,795,000.00 | -55,917,000.00 | -56,186,000.00 | -56,704,000.00 | -86,042,000.00 | -27,052,000.00 | -27,616,000.00 |
| 投入资本(元) | 32,355,000.00 | 25,915,000.00 | 38,929,000.00 | 38,425,000.00 | 41,134,000.00 | 47,305,000.00 | 52,783,000.00 | 78,970,000.00 |
| 经营活动产生的现金流量净额TTM(元) | -20,032,000.00 | -22,431,000.00 | -22,846,000.00 | -23,724,000.00 | -21,170,000.00 | -19,306,000.00 | -20,347,000.00 | -19,912,000.00 |
| 归属母公司净利润TTM(元) | -20,840,000.00 | -21,465,000.00 | -53,587,000.00 | -56,186,000.00 | -54,225,000.00 | -82,592,000.00 | -24,573,000.00 | -23,629,000.00 |
| 所得税TTM(元) | -2,330,000.00 | -2,330,000.00 | -2,330,000.00 | -2,479,000.00 | -2,479,000.00 | -3,450,000.00 | -2,479,000.00 | -1,508,000.00 |